Autoimmune and immune-mediated inflammatory diseases after exposure to acid-suppressive medication: A systematic review and meta-analysis
International Journal of Risk & Safety in Medicine · 2023
DOI: 10.3233/jrs-220012 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Risk & Safety in Medicine, 2023. Verfasst von Anna Nevalainen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Colitis, Microscopic. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pharmacovigilance risk signals have proposed a relationship between the use of acid-suppressive medications and the development of certain autoimmune and immune-mediated inflammatory diseases. OBJECTIVE: A systematic review and a meta-analysis was performed. METHODS: We reviewed MEDLINE (Ovid) and Scopus for comparative observational studies between these diseases and previous exposure to proton-pump inhibitors (PPI), H2-receptor antagonists (H2RA), and antacids. The protocol was registered on the PROSPERO database (CRD42020192715). RESULTS: From 3,191 citations, 25 articles were eligible and covered 16 diseases. Microscopic colitis (MC) was studied the most (7 studies). In a random-effects meta-analysis, there was low certainty evidence (GRADE approach) of a non-significant relationship between exposure to any PPIs and MC (meta-OR 3.28, 95% CI 0.98–11.0, I2 98.2%, six studies, 4,436 PPI-exposed MC patients). Moderate certainty evidence pointed towards large odds of collagenous colitis after exposure to lansoprazole (meta-OR 14.5, 95% CI 9.37–22.3, I2 10.2%, three studies, 1,725 lansoprazole-exposed patients). After PPI exposure, the risk of rheumatoid arthritis was slightly increased based on low certainty evidence from two cohort studies totaling 475 diagnoses (meta-RR 1.62, 95% CI 1.12–2.34, I2 34.5%). CONCLUSIONS: In patients with MC, it would be reasonable to carefully review the indication of PPI, especially in CC patients using lansoprazole.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Independent Researcher, Groningen, The Netherlands.
- Hatanpää Health Centre, City of Tampere, Tampere, Finland.
- Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Zitieren
APA
Nevalainen, A., & Nevalainen, O. P. O. (2023). Autoimmune and immune-mediated inflammatory diseases after exposure to acid-suppressive medication: A systematic review and meta-analysis. International Journal of Risk & Safety in Medicine. https://doi.org/10.3233/jrs-220012
Vancouver
Nevalainen A, Nevalainen OPO. Autoimmune and immune-mediated inflammatory diseases after exposure to acid-suppressive medication: A systematic review and meta-analysis. International Journal of Risk & Safety in Medicine. 2023. doi:10.3233/jrs-220012
BibTeX
@article{Nevalainen2023,
author = {Nevalainen, Anna and Nevalainen, Olli P O},
title = {Autoimmune and immune-mediated inflammatory diseases after exposure to acid-suppressive medication: A systematic review and meta-analysis},
journal = {International Journal of Risk & Safety in Medicine},
year = {2023},
doi = {10.3233/jrs-220012}
}
EUVIMED